Abingdon Health’s core technology is based on rapid lateral flow immunoassay diagnostics and associated reader systems.
We are also developing the next generation of multiplexed rapid diagnostics technology to meet the market need for simple to use, rapid, cost effective, portable system.
£2.5m National Lottery bid secured for the Forest of Dean https://t.co/tmjdioqnFJ
25 April 2017
© Abingdon Health 2017